Drug factory · FDA FEI 3002806542
Takeda GmbH
Robert-Bosch-Str. 8, Singen (Hohentwiel), Germany
Problems found, fixed voluntarily at FDA's last inspection, Nov 12, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
7 drug inspections on record since 2009: 3 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Pantoprazole | Makes it, tests it, packages it and labels it | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0008-0841, 0008-0843, 0008-0844 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 12, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 6, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 27, 2018 | No problems found | Drug Quality Assurance | — |
| Apr 22, 2016 | No problems found | Drug Quality Assurance | — |
| Feb 21, 2014 | No problems found | Drug Quality Assurance | — |
| Apr 27, 2012 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 10, 2009 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.